Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders
Advanced Drug Delivery Reviews · 2025-05 · 220 · 115561
DOI: 10.1016/j.addr.2025.115561 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2025-05. Verfasst von Marion Le Meur und 3 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), 28049 Madrid, Spain; Dipartimento di Farmacia e Biotecnologie (FaBiT), …. Hauptthemen laut MEDLINE: Circadian Clocks, Nervous System Diseases, Nanoparticles, Drug Delivery Systems. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 254 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Microsoft, H2020 Marie Skłodowska-Curie Actions, Ministerio de Ciencia e Innovación.
Abstract (Originalsprache)
Circadian rhythms and their involvement with various human diseases, including neurological disorders, have become an intense area of research for the development of new pharmacological treatments. The location of the circadian clock machinery in the central nervous system makes it challenging to reach molecular targets at therapeutic concentrations. In addition, a timely administration of the therapeutic agents is necessary to efficiently modulate the circadian clock. Thus, the use of nanoparticles in circadian clock dysfunctions may accelerate their clinical translation by addressing these two key challenges: enhancing brain penetration and/or enabling their formulation in chronodelivery systems. This review describes the implications of the circadian clock in neurological pathologies, reviews potential molecular targets and their modulators and suggests how the use of nanoparticle-based formulations could improve their clinical success. Finally, the potential integration of nanoparticles into chronopharmaceutical drug delivery systems will be described.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), 28049 Madrid, Spain; Dipartimento di Farmacia e Biotecnologie (FaBiT), Alma Mater Studiorum - Università di Bologna, 40127 Bologna, Italy.
- Cajal Institute, Consejo Superior de Investigaciones Científicas (CSIC), 28002 Madrid, Spain; Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Madrid,…
- Dipartimento di Farmacia e Biotecnologie (FaBiT), Alma Mater Studiorum - Università di Bologna, 40127 Bologna, Italy. Electronic address: p.blasi@unibo.it.
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), 28049 Madrid, Spain; Biomedical Research Networking Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, 28029 Mad…
Förderung
- Microsoft
- H2020 Marie Skłodowska-Curie Actions
- Ministerio de Ciencia e Innovación
- European Commission
- Faculty of Science and Engineering, University of Manchester
- State Agency of Research
Zitieren
APA
Le Meur, M., Pignatelli, J., Blasi, P., & Palomo, V. (2025). Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders. Advanced Drug Delivery Reviews, 220, 115561. https://doi.org/10.1016/j.addr.2025.115561
Vancouver
Le Meur M, Pignatelli J, Blasi P, Palomo V. Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders. Advanced Drug Delivery Reviews. 2025;220:115561. doi:10.1016/j.addr.2025.115561
BibTeX
@article{LeMeur2025,
author = {Le Meur, Marion and Pignatelli, Jaime and Blasi, Paolo and Palomo, Valle},
title = {Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders},
journal = {Advanced Drug Delivery Reviews},
year = {2025},
volume = {220},
pages = {115561},
doi = {10.1016/j.addr.2025.115561}
}
EUVIMED